UnitedHealth Group Inc (UNH), MGIC Investment Corp. (MTG), and More: Why These Stocks Are Trending Today

Page 2 of 2

MGIC Investment Corp. (NYSE:MTG) shares are 3% in the green after the company reported third-quarter EPS of $0.25 and revenue of $273.85 million, which topped analyst expectations by $0.06 and $13.91 million, respectively. New insurance written advanced by 14.4% year-over-year to $14.2 billion, helping insurance in force inch up 4.3% on the year to $180.1 billion. Book value per share rose to $7.48 from $6.33 per share in the third quarter of 2015. The number of funds from our database with holdings in MGIC Investment Corp. (NYSE:MTG) rose by nine quarter-over-quarter to 46 at the end of June.

Follow Mgic Investment Corp (NYSE:MTG)

MakeMyTrip Limited (NASDAQ:MMYT) shares have surged 44% following news that the company had agreed to pursue a transaction that will combine ibibo Group and MakeMyTrip under the MakeMyTrip umbrella, creating one of the leading travel groups in India that processed 34.1 million transactions during fiscal 2016. MakeMyTrip’s management expects the deal to unlock value for customers, supply partners and shareholders and the transaction is expected to close by the end of this year. A total of 13 funds followed by our team held shares of MakeMyTrip Limited (NASDAQ:MMYT) at the end of the second quarter, down by one from the previous quarter.

Follow Makemytrip Limited (NASDAQ:MMYT)

Abeona Therapeutics Inc (NASDAQ:ABEO) has rallied 12% on the back of the announcement that it has received the orphan drug designation from the EMA for ABO-102 gene therapy in Sanfilippo Syndrome Type A. ABO-102 has previously been granted the Orphan product designation from the FDA earlier. The designation status provides incentives and benefits in the EU, including reduced fees and protection from market competition if ABO-102 is approved for the treatment of MPS IIIA patients. Nine funds from our database held $14.53 million worth of Abeona Therapeutics Inc (NASDAQ:ABEO)’s stock, which accounted for 18.90% of the float on June 30, versus seven funds and $15.35 million, respectively, on March 31.

Follow Abeona Therapeutics Inc. (NASDAQ:ABEO)

Disclosure: none

Page 2 of 2